---
title: lipid disorders
---

- from: [[endocrinology]] ó°’–

# lipid disorders

- [[Measurements-lipid disorders]]
- [[dyslipidemias]]
- [[Drug Treatment-lipid disorders]]
- [[Treatment of LDL-C]] (Lancet 2014;384:607)
- [[Treatment of other lipid fractions]] (Lancet 2014;384:618 & 626)
- [[2018 ACC AHA Cholesterol Guidelines]] (Circ 2019;139:e1082)
- [[statins actions, side effects, and administration]]

| Condition                             | LDL-C Target          |
| ------------------------------------- | --------------------- |
| ACS + DM                              | < 55 mg/dL            |
| ACS                                   | < 70 mg/dL            |
| Stable CAD                            | < 70 mg/dL            |
| PAD + CAD                             | < 70 mg/dL            |
| PAD                                   | < 100 mg/dL           |
| ACS, Stable CAD, PAD (TG > 200 mg/dL) | Non-HDL-C < 100 mg/dL |
